Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol for postoperative sleep quality in children undergoing tonsil/adenoid surgery
ChiCTR2400085630Phase 4Not yet recruiting
- Sponsor
- Affiliated Women and Children's Hospital of Ningbo University
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in Tonsillar hyperplasia and adenoidal hypertrophy (2 arms), sponsored by Affiliated Women and Children's Hospital of Ningbo University. Primary endpoint: postoperative sleep quality. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
Tonsillar hyperplasiaadenoidal hypertrophy
Beyond the preview
Go deeper on ChiCTR2400085630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400085630.